EmergentBioSolutions

Report: U.S. cancels vaccine maker’s multimillion-dollar deal

Report: U.S. cancels vaccine maker’s multimillion-dollar deal

By The Associated Press Troy Warren for CNT #COVID-19 #Business WASHINGTON — The federal government has canceled a multimillion-dollar deal with Emergent BioSolutions, a Maryland-based vaccine manufacturer with facilities in Baltimore that were found to have produced millions of contaminated Johnson & Johnson vaccine doses this spring, The Washington Post reported. Emergent disclosed the development Thursday in a conference call discussing its latest financial results, the Post reported. Emergent said it will forgo about $180 million due to the contract’s termination, according to the Post. Emergent BioSolutions played a role in the Trump administration’s effort to speed up vaccine development and…
Read More